Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

Abbott

Status: Completed

Conditions: Multi-site Left Ventricular Pacing

Study type: Observational

Funder types: Industry

Identifiers

NCT01044472

CR-09-048-EU-HF

Details and patient eligibility

About

The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

Full description

To evaluate the hemodynamic impact of different pacing MSLV configurations.

Enrollment: 61 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system.
• Patients have signed an informed consent form indicating their willingness to participate to this study.

Exclusion criteria

• Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason.
• Patients with second or third degree AV Block
• Patients with intrinsic atrial rhythm < 40 bpm
• Patients with a previously implanted left ventricular pacing lead.
• Patients who are pregnant.
• Patients currently participating in a clinical investigation that includes an active treatment arm.
• Patients under 18 years of age.
• Patients with a life expectancy of less then 6 months.